All In MedTech

Device Trial Radar · NCT05830968

Safety and Efficacy of Radio Frequency for the Treatment of Mild to Severe Inflammatory Acne

Clinical Evaluation of Safety and Efficacy of the InMode RF Pro System With the Morpheus8 Applicator for the Treatment of Mild to Severe Inflammatory Acne Vulgaris

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

46

Actual

Start

May 1, 2023

Primary completion

May 1, 2025

Study completion May 1, 2026

Sponsor

Lead sponsor
InMode MD Ltd.Public (INMD)
Sponsor type
Industry
First posted
Apr 26, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 16 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The aim of this trial is to evaluate the safety and efficacy of the InMode RF Pro System with the Morpheus8 face tip (24 pins) applicator for the treatment of mild, moderate and severe, facial acne vulgaris

Conditions

  • Inflammatory Acne Vulgaris

Interventions

  • Morpheus8 Applicator Radiofrequency deviceDevice

    Eligible subjects will receive 2 treatments with the Morpheus8 according to the study protocol. All participants will return for 2 follow up visits: 4 weeks (1M FU) and 12 weeks (3M FU) after the 2nd treatment. Total expected study duration is \~6 months, depending on subject recruitment rate.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent of responderTime frame: Month 3

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Avant Dermatology Aesthetics

    Oro Valley, Arizona

  • AboutSkin Research, LLC

    Greenwood Village, Colorado

  • UnionDerm

    New York, New York

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.